FMS icon

Fresenius Medical Care

24.35 USD
+0.05
0.21%
At close Feb 7, 4:00 PM EST
After hours
24.35
+0.00
0.00%
1 day
0.21%
5 days
-0.29%
1 month
7.36%
3 months
14.16%
6 months
34.38%
Year to date
9.93%
1 year
23.67%
5 years
-38.29%
10 years
-32.99%
 

About: Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.

Employees: 113,079

0
Funds holding %
of 6,831 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

27% more call options, than puts

Call options by funds: $1.7M | Put options by funds: $1.34M

16% more capital invested

Capital invested by funds: $617M [Q2] → $713M (+$96.4M) [Q3]

15% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 20

14% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 49

0.39% more ownership

Funds ownership: 11.02% [Q2] → 11.41% (+0.39%) [Q3]

1% less funds holding

Funds holding: 165 [Q2] → 164 (-1) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$25
3%
upside
Avg. target
$25
3%
upside
High target
$25
3%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Truist Securities
David Macdonald
65% 1-year accuracy
62 / 95 met price target
3%upside
$25
Hold
Maintained
6 Jan 2025

Financial journalist opinion

Positive
Seeking Alpha
1 week ago
Fresenius Medical Care: A 'Buy' Going Into 2025
Fresenius Medical Care is a leader in global kidney care, showing significant growth and an 18.5% increase since my last article. The company is attractively valued, trading at less than 18.5x P/E, with a fair value estimate of at least $34/share. Risks include political factors in the US healthcare system and technological advancements, but the company's diversification and home-care model are strong positives.
Fresenius Medical Care: A 'Buy' Going Into 2025
Positive
Zacks Investment Research
1 month ago
Fresenius (FMS) Upgraded to Strong Buy: Here's What You Should Know
Fresenius (FMS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Fresenius (FMS) Upgraded to Strong Buy: Here's What You Should Know
Positive
Zacks Investment Research
1 month ago
Best Income Stocks to Buy for January 7th
PRMB, FMS and RBA made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 7, 2024.
Best Income Stocks to Buy for January 7th
Positive
Zacks Investment Research
1 month ago
Best Value Stocks to Buy for January 7th
FMS, SVM and CNO made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 7, 2024.
Best Value Stocks to Buy for January 7th
Positive
Zacks Investment Research
1 month ago
Best Momentum Stocks to Buy for December 27th
PAYO, TTDKY and FMS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 27, 2024.
Best Momentum Stocks to Buy for December 27th
Positive
Zacks Investment Research
1 month ago
Best Income Stocks to Buy for December 27th
TTDKY, FMS and FHB made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 27, 2024.
Best Income Stocks to Buy for December 27th
Positive
Zacks Investment Research
1 month ago
Best Value Stocks to Buy for December 27th
AAL, FMS and TTDKY made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 27, 2024.
Best Value Stocks to Buy for December 27th
Neutral
PRNewsWire
1 month ago
Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index
Ranking puts Fresenius Medical Care among the best-in-class sustainability performers in the world and Europe The company recorded progress towards its sustainability targets Sustainability is one of the essential drivers for future BAD HOMBURG, Germany , Dec. 23, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has been recognized as a sustainability leader with the inclusion in the Dow Jones Sustainability World Index and with the inclusion in the Dow Jones Sustainability Europe Index for the 15th time. Dow Jones Sustainability Index (DJSI) is one of the world's leading ESG (Environmental, Social, Governance) stock indices.
Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index
Neutral
PRNewsWire
1 month ago
Fresenius Medical Care returns to Dax 40 Index
BAD HOMBURG, Germany , Dec. 20, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, will return to the top tier of the German Stock Index, the DAX 40, as of December 27, 2024. The index represents the performance of the 40 largest publicly traded companies listed on the Frankfurt Stock Exchange and accounts for around 80 percent of the market capitalization of listed stock corporations in Germany.
Fresenius Medical Care returns to Dax 40 Index
Positive
Zacks Investment Research
1 month ago
4 Value Stocks to Buy as Wall Street Awaits Fed's Rate Decision
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. TSN, GM, FMS and DLX boast a low P/CF ratio.
4 Value Stocks to Buy as Wall Street Awaits Fed's Rate Decision
Charts implemented using Lightweight Charts™